Introduction
============

The association between obesity and cardiovascular (CV) all-cause mortality is well established and is attributed to the negative impact of excess body fat. However, there is still discussion about visceral obesity and its impact on mortality, and especially the effect of this relationship among the elderly. Large collaborative studies using body mass index (BMI) to define obesity have shown that the mortality risk associated with obesity markedly declines with age.[@b1-vhrm-9-739],[@b2-vhrm-9-739] By contrast, the risk persists, even in the highest age categories, in studies using waist circumference (WC) to define obesity.[@b3-vhrm-9-739],[@b4-vhrm-9-739] However, we have shown in a large population that WC and metabolic syndrome have limited prognostic value in older patients, confirming smaller studies.[@b5-vhrm-9-739],[@b6-vhrm-9-739],[@b7-vhrm-9-739] These discrepant results may be accounted for by the limitations of the criteria used to define obesity in clinical practice. BMI is based on body weight and height only and does not directly reflect adiposity. WC is strongly related to central adiposity[@b8-vhrm-9-739] and is associated with CV risk factors, such as hypertension, dyslipidemia, and glucose intolerance.[@b9-vhrm-9-739] The physiopathological links include inflammation, excessive oxidative stress, and insulin resistance − all deleterious phenomena. While they are quite strongly associated with each other, particularly in individuals with high body corpulence,[@b10-vhrm-9-739] WC and BMI appear to measure distinct features of body composition. For a given BMI value, the WC reflects the abdominal fat deposits. Conversely, for a given WC, the BMI probably reflects non-abdominal as well as abdominal fat deposits and possibly fat-free mass.[@b11-vhrm-9-739] The discrepancy between these two measures is likely to increase with advancing age, compounding the assessment of the impact of aging on the prognostic significance of obesity. BMI-adjusted WC may be a better marker of central adiposity than WC alone.[@b11-vhrm-9-739] Another important element is the duration of exposure to these risk factors. Older patients with recent obesity, hypertension, dyslipidemia, and diabetes may not be threatened with the same mortality risk as patients who have presented these risk factors for many years or decades. Metabolic syndrome was previously studied in our population (but was not assessed in this study).[@b5-vhrm-9-739] Finally, the absolute mortality risk associated with obesity may result in a significantly elevated relative risk in young persons, but not in older persons, for whom a higher all-cause mortality rate is due to age per se or to comorbidities.

The aim of the study was to determine the role of obesity evaluated by BMI, WC, and their combined effect on all-cause mortality according to age and related risk factors, in a large French population.

Methods and procedures
======================

Participants were examined at the Centre d'Investigations Préventives et Cliniques (IPC Center), Paris, France. This medical center, which is subsidized by the French national health care system, offers all working and retired individuals and their families a free medical examination every 5 years. It is one of the largest medical centers of this kind in France, carrying out \~25,000 health examinations per year for people living in the Paris area. The IPC Center received authorization from the Comité National d'Informatique et des Libertés to conduct and publish these analyses. All subjects gave informed consent at the time of the examination.

The study population, consisting of 129,655 subjects, has been described previously.[@b5-vhrm-9-739] In a preliminary analysis, it was found that the association between mortality and obesity was weaker when patients with a low BMI or a short follow-up were included.

Because subjects with very low BMI or subjects who died during the first 2 years of follow-up (representing 8.1% of our population) had a large probability of having previously undiagnosed pathologies, which could modify the relation between obesity and mortality, the present analysis involved 119,090 subjects, aged from 17 years to 85 years, who had a BMI \>20 kg/m^2^ and a follow-up of at least 2 years. The patients were evaluated between January 1999 and December 2006. Follow-up for all-cause mortality was obtained until December 2008. The mean follow-up was 5.6±2.4 years. During this period, 1,259 subjects died (954 men and 305 women).

Data collection, laboratory measurements, and follow-up
-------------------------------------------------------

WC was measured in the standing position, using a tape placed midway between the lower ribs and iliac crests on the midaxillary line. BMI (kg/m^2^) was calculated from the measured height and body weight. Supine blood pressure was measured in the right arm using a manual mercury sphygmomanometer, after a 10-minute rest. The first and the fifth Korotkoff phases were used to define the systolic blood pressure (BP) and diastolic BP. Three measurements were taken, and the mean of the last two was used. Standard biological parameters were measured by enzymatic methods using a Hitachi 917 automated analyzer (Hitachi Ltd, Tokyo, Japan); High-density lipoprotein (HDL) cholesterol was measured by direct enzymatic assay using cyclodextrin and low-density lipoprotein (LDL) cholesterol was calculated using the Friedwald formula. A resting electrocardiogram (EKG) was recorded. A cardiologist encoded EKG abnormalities as rhythmic disorders, QRS complex abnormalities, or depolarization disturbance. Tobacco consumption (never smoker, ex-smoker, or current smoker), physical activity (\>2 hours regular physical activity per week), personal medical history, current medication, and alcohol consumption were assessed using a self-administered questionnaire. White-collar workers were categorized as "high socioprofessionals." All clinical and biological parameters were evaluated at a single visit. For each screened subject, vital status was obtained from the French National Institute of Statistics and Economic Studies (Institut National de Statistiques et d'Etudes Economiques), as previously validated and described.[@b12-vhrm-9-739]

Statistics
----------

Patient characteristics were compared according to age groups (\<55, 55--65 years, \>65 years) using analysis of variance (ANOVA) for quantitative parameters, and chi-square tests for dichotomous variables. The distribution of subjects and percentage of deaths according to BMI categories (20--24.9 kg/m^2^, 25--29.9 kg/m^2^, ≥30 kg/m^2^) and WC categories (\<94 cm, 94--101 cm, ≥102 cm, in men; and \<80 cm, 80--87 cm, ≥88 cm, in women) were analyzed using the chi-square test. The risk of all-cause mortality associated with BMI (kg/m^2^) and WC (cm) was further evaluated using Cox regression analysis. Hazard ratios (HRs) were calculated per one unit of each parameter. The effect of age on these associations was evaluated again after dividing the population into the three age groups. The analysis was first performed including age, sex, previous CV events, EKG abnormalities, current smoking, socioprofessional category, physical activity, and family history of diabetes and CV disease. An adjustment for hypertension, lipid level, and diabetes, which reflect possible mechanisms by which obesity increases mortality, was made in separate, subsequent steps. For these analyses, hypertension was defined as systolic BP \>140 mmHg, diastolic BP \>90 mmHg, or ongoing antihypertensive treatment, and diabetes was defined as a fasting serum glucose \>126 mg/dL or ongoing treatment. Current smokers were compared with the pooled subgroups of nonsmokers and former smokers. Previous CV events represented previous myocardial infarction or stroke, by self-report. For obesity markers, different models were used, and BMI and WC were further adjusted for each other (WC adjusted for BMI and BMI adjusted for WC).

All statistical analyses, including interactions, were performed using SAS 8.2 statistical software (SAS Institute Inc, Cary, NC, USA).

Results
=======

Population characteristics
--------------------------

The study participant characteristics according to age groups (\<55 years, 55--65 years, \>65 years) and sex are shown in [Table 1](#t1-vhrm-9-739){ref-type="table"}. The prevalence of elevated WC (≥88 cm in women, ≥102 cm in men) markedly increased with age, whereas the increase in elevated BMI (≥30 kg/m^2^) was less pronounced. The prevalence of hypertension and diabetes also increased with age. The mean values of all lipid parameters were higher in the 55--65 years age group than in the \<55 years age group. For total cholesterol and LDL cholesterol, the levels increased linearly with age in women. By contrast, in men, total cholesterol and LDL cholesterol decreased among subjects over 65 years of age. HDL cholesterol increased with age, in both men and women.

All-cause mortality associated with obesity in the entire population
--------------------------------------------------------------------

[Figure 1](#f1-vhrm-9-739){ref-type="fig"} shows all-cause mortality rates (%) according to WC and BMI categories, in women and men. In both sexes, mortality was higher in participants with a high WC within the three BMI categories (*P*\<0.001 for all). In women, for any given WC category, mortality was lower in the higher BMI categories. In men, this was observed for the two lowest categories of WC. So this inverse association was most clearly observed in both men and women with an intermediate WC (*P*\<0.001). Obesity was analyzed as continuous variables using multiple Cox models in the global population, which showed that BMI (HR =1.024 per BMI unit, 95% confidence interval \[CI\]: 1.010--1.040, *P*=0.0012) and the WC (HR =1.015 per centimeter, 95% CI: 1.010--1.021, *P*\<0.0001) were both associated with mortality, after adjustment for age, sex, previous CV events, EKG abnormalities, smoking, socioprofessional category, physical activity, and family history of diabetes and CV disease. However, when BMI and WC were further adjusted for each other, WC adjusted for BMI predicted mortality more strongly (HR =1.025 per centimeter, 95% CI: 1.016--1.035, *P*\<0.0001), and BMI adjusted for WC became negatively associated with mortality (HR 0.967, 95% CI: 0.943--0.992, *P*=0.01). All these associations were affected very little by further adjustment for hypertension, dyslipidemia, and diabetes (data not shown).

The effect of age on the association between waist circumference, body mass index, and all-cause mortality
----------------------------------------------------------------------------------------------------------

[Figure 2](#f2-vhrm-9-739){ref-type="fig"} shows all-cause mortality rates (%) according to WC and BMI categories in individuals \<55 years, 55--65 years, and \>65 years. In all age groups, for any given level of WC, BMI was not associated with all-cause mortality (*P*\>0.10). Interestingly, in young (\<55 years) subjects, mortality was strongly positively associated with WC, at any given level of BMI ([Figure 1A](#f1-vhrm-9-739){ref-type="fig"}). A similar trend was observed in individuals 55--65 years, though these results were less significant ([Figure 1B](#f1-vhrm-9-739){ref-type="fig"}). In the older group, no such association was observed ([Figure 1C](#f1-vhrm-9-739){ref-type="fig"}). These results were also confirmed in multivariate analyses, shown in [Table 2](#t2-vhrm-9-739){ref-type="table"}. WC adjusted for BMI was strongly associated with mortality in the two youngest groups. By contrast, this parameter was not associated with mortality in subjects \>65 years (*P* interaction =0.0046). Interestingly, age, hypertension, and current smoking were all significantly associated with mortality in subjects \>65 years, in multivariate analysis. Similar results were obtained when the analysis were carried without excluding those individuals with BMI \<20 kg/m^2^ or those who died the first 2 years (data not shown). Finally, we repeated the Cox analysis excluding patients with previous CV events or with EKG abnormalities. Even in this subpopulation, WC adjusted for BMI was associated with mortality in subjects \<55 years (HR =1.028, CI: 1.012--1.044, *P*\<0.001) and 55--65 years (HR =1.033, CI: 1.014--1.052, *P*\<0.001) but not in subjects \>65 years (HR =1.013, CI: 0.939--1.066, *P*=NS).

Discussion
==========

The present results demonstrate that WC was an obesity parameter that was strongly associated with mortality in the entire study population, even after adjustment for BMI. This effect was stronger in younger persons and disappeared after the age of 65 years.

WC is widely accepted as a clinical marker of central obesity or visceral fat deposition.[@b4-vhrm-9-739],[@b13-vhrm-9-739] The primary result of our study was that WC adjusted for BMI was not associated with mortality in subjects \>65 years. Conversely, the inverse association between BMI adjusted for WC and mortality was found only in the population \<55 years. These same conclusions were reached with or without the exclusion of patients with previous CV events. By contrast, smoking and hypertension remained associated with all-cause mortality in this age group. It is most unlikely that our findings are accounted for by the smaller size of the subpopulation \>65 years, which represented about 6,000 subjects. Actually, the persistence in this age group, of the associations between mortality and other risk factors, such as smoking and hypertension, argue against this hypothesis. The association between all-cause mortality and obesity may also be compounded by reverse causality, whereby low BMI and/or short-term mortality reflect the impact of an underlying disease. However, subjects with a BMI \<20 kg/m^2^ and patients with \<2 years follow-up were excluded from the present analysis to minimize the possible impact of this phenomenon. Contrary to WC, which is a good index of visceral fat deposition, BMI might reflect several components of body composition and not only skeletal fat. It is clearly possible that muscle loss is higher in elderly people than in younger people, without there being any relationship with visceral fat.

There are many putative reasons to explain the lack of association between central obesity and mortality in older subjects. The first hypothesis is linked to a major population effect and is as follows: Obese subjects with higher risk of death cannot reach the age of \>65 years or have experienced several severe diseases and thus, cannot be observed in our recruited population. However, the prevalence and exposure duration are likely to play an important role. In the present study we noted a markedly higher prevalence of high WC in participants \>65 years compared with participants 55--65 years. This suggests that a substantial proportion of obese participants \>65 years have been obese for only a few years. A recent study in young adults showed that the risk of coronary heart disease associated with obesity was strongly amplified if obesity was already present at adolescence,[@b14-vhrm-9-739] implying that obesity increases the risk of CV disease only after decades of exposure. Obesity acquired around the age of retirement may have a much weaker impact than if present since early adulthood, as a result of a possibly lifelong poor lifestyle. A short exposure time in a significant proportion of older participants may have "diluted" the prognostic significance of longstanding central obesity.

Our findings corroborate results from several studies that show no association between central obesity and/or metabolic syndrome in older populations.[@b5-vhrm-9-739],[@b6-vhrm-9-739],[@b7-vhrm-9-739],[@b15-vhrm-9-739],[@b16-vhrm-9-739] However, they are at apparent odds with previous studies that found a significant association between WC (with or without adjustment for BMI) and mortality, even in subjects \>70 years.[@b3-vhrm-9-739],[@b4-vhrm-9-739],[@b17-vhrm-9-739] The prevalence and presumably the duration of exposure to obesity were much lower in our study than those in studies from the USA,[@b3-vhrm-9-739],[@b17-vhrm-9-739] possibly accounting in part for a lower prognostic impact. This explanation cannot account for the differences with the European Prospective Investigation into Cancer and Nutrition (EPIC) study,[@b4-vhrm-9-739] in which the prevalence of obesity was apparently quite similar to our study. In this European study, the overall mortality rate was substantially higher, perhaps due in part, to the geographic origin of the study populations, mostly recruited in Northern Europe.[@b18-vhrm-9-739] It is quite possible that the higher mortality associated with obesity was related to a higher prevalence and prognostic impact of related risk factors. However, associated risk factors were not assessed in the EPIC study.

Interestingly, hypertension was the conventional risk factor most strongly associated with mortality in participants \>65 years. The impact of hypertension on mortality may have been underestimated, in the present study, by the effect of antihypertensive treatments. Furthermore, the diagnosis of hypertension was based on clinical measures, which are expected to misclassify many participants due to the role of "white coat" hypertension. The impact of hypertension in older participants could actually be demonstrated only when previous CV events and EKG abnormalities were excluded from the analysis. It is possible that the association between hypertension and mortality is in part, accounted for by previously accumulated arterial disease or arterial aging.[@b19-vhrm-9-739],[@b20-vhrm-9-739] The impact of smoking may have been underestimated by the exclusion of patients with short follow-up or low BMI and by the inclusion of former smokers in the denominator group. These considerations further emphasize the low relative risk associated with obesity in older subjects in this population. From a physiopathological point of view, visceral fat deposition is deleterious in at least the two following major ways: insulin resistance and inflammation. Our results suggest that in the elderly, these phenomena might have less impact on mortality than other diseases not associated with visceral obesity. Mortality rates are substantially higher in men and women \>65 years than in younger subjects.

Our study had some limitations. It included very few participants with a BMI \>35 kg/m^2^ (1.54% \[n=1220\] among the men and 3.96% \[n=1576\] among the women), therefore, our conclusions do not apply to subjects with severe (class II or class III) obesity. In addition, the population was self-referred on a voluntary basis. Inclusion by self-referral may select health-conscious participants with a low prevalence of associated disorders. For instance, patients with severe diabetes or hypertension may exclude themselves from a primary care checkup as they already benefit from specialized care. However, this study population is seen in a primary care setting, where the identification of modifiable risk factors is clinically most relevant. The follow-up period of 5.6±2.4 years was rather short, considering the time frame over which obesity exerts its detrimental effects. It is quite possible that obesity-related mortality in older subjects would have been demonstrated with a longer follow-up. However, this limitation cannot account for the decline in obesity-related mortality with aging, nor for the low risk associated with obesity in comparison with other risk factors, such as hypertension and smoking.

In summary, after taking into account associated risk factors, we found that the role of central obesity evaluated by WC adjusted for BMI is significantly associated with all-cause mortality, except in the elderly. By contrast, an inverse relationship between obesity evaluated by BMI or BMI adjusted for WC and mortality was observed. These results clearly indicate that WC and BMI provide distinct prognostic information. The prognostic significance of central obesity, but not of hypertension or smoking, declines with age. These results do not deny the importance of preventing obesity even in older subjects because obesity clearly remains an important risk factor of functional disabilities[@b21-vhrm-9-739] in older subjects. Our data suggest that treatment for hypertension and smoking cessation have a greater potential for decreasing mortality than does weight reduction, especially if obesity is of recent onset.
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![Unadjusted rates for all-cause mortality in (**A**) women and (**B**) men, according to BMI and WC categories, in the entire study population.\
**Note:** In men with a WC \>102 cm and a BMI of 20--24.9 kg/m^2^, mortality was 8.2% (4/49 participants) (data not shown).\
**Abbreviations:** BMI, body mass index; WC, waist circumference.](vhrm-9-739Fig1){#f1-vhrm-9-739}

![Mortality rates (%), according to WC and BMI, in individuals (**A**) \<55 years, (**B**) 55--65 years, and (**C**) \>65 years.\
**Notes:** WC classification was sex-specified. For men, WC1: \<94 cm; WC2: 94--101 cm; WC3: ≥102 cm. For women, WC1: \<80 cm; WC2: 80--87 cm; WC3: ≥88 cm. *P*-values indicate the effect of WC in each BMI group.\
**Abbreviations:** BMI, body mass index; WC, waist circumference.](vhrm-9-739Fig2){#f2-vhrm-9-739}

###### 

Population characteristics (mean ± SEM for quantitative variable and % \[n\] for dichotomous variables), according to age groups

                                                                               Men             Women                                                                                  
  ---------------------------------------------------------------------------- --------------- -------------- -------------- ---------- --------------- -------------- -------------- ----------
  N                                                                            63,365          12,876         3,084                     28,649          7,799          3,317          
  Age (years)                                                                  40.7±8.7        58.5±2.7       68.9±3.3                  39.3 (10.1)     58.9 (2.7)     69.3 (3.3)     
  Weight (kg)                                                                  78.2±11.8       78.9±11.7      77.4±11.3      \<0.0001   65.3±12.2       65.5±11.3      64.8±11.0      0.002
  Height (cm)                                                                  175.2±6.9       172.3±6.7      170.4±6.7      \<0.0001   161.9±6.5       159.7±6.1      157.3±6.2      \<0.0001
  BMI (kg/m^2^)                                                                25.4±3.4        26.5±3.5       26.6±3.4       \<0.0001   24.9 (4.5)      25.7±4.3       26.2±4.3       \<0.0001
  BMI \>30 kg/m^2^, % (n)                                                      9.6 (6,086)     14.8 (1,906)   16.0 (493)     \<0.0001   12.9 (3,701)    14.8 (1,157)   16.7 (553)     \<0.0001
  Waist circumference (cm)                                                     88.3±9.9        93.5±9.8       95.2±10.0      \<0.0001   77.5±10.7       81.0±10.9      83.9±11.2      \<0.0001
  Waist circumference high, % (n)[\*](#tfn2-vhrm-9-739){ref-type="table-fn"}   9.6 (6,100)     19.1 (2,468)   25.8 (797)     \<0.0001   15.9 (4,564)    23.6 (1,839)   33.0 (1,096)   \<0.0001
  Hypertension, % (n)                                                          26.9 (17,065)   52.4 (6,742)   65.6 (2,024)   \<0.0001   17.6 (5,040)    45.4 (3,544)   64.6 (2,144)   \<0.0001
  Treated hypertension, % (n)                                                  1.7 (1,088)     9.2 (1,189)    19.6 (604)     \<0.0001   2.9 (828)       12.8 (996)     22.94 (761)    \<0.0001
  SBP (mmHg)                                                                   130.1±16.4      140.2±19.6     146.3±20.9     \<0.0001   122.7±17.3      136.6±20.4     147.1±22.2     \<0.0001
  DBP (mmHg)                                                                   77.6±11.7       84.6±11.7      84.39±11.6     \<0.0001   74.1±11.2       79.4±11.7      80.9±12.0      \<0.0001
  Total cholesterol (mg/dL)                                                    211.4±0.2       224.5±0.4      218.7±0.73     \<0.0001   200.8±0.24      232.0±0.5      235.9±0.7      \<0.0001
  LDL cholesterol (mg/dL)                                                      134.5±0.1       143.5±0.3      138.0±0.7      \<0.0001   118.±0.2        141.3±0.4      143.8±0.6      \<0.0001
  HDL cholesterol (mg/dL)                                                      55.3±13.8       57.2±14.4      58,1±14,6      \<0.0001   66.1±16.5       71.5±17.6      71.6±17.5      \<0.0001
  Triglycerides (mg/dL)                                                        108.1±67.5      118.8±71.9     113.3±59.7     \<0.0001   79.3±40.1       96.0±47.8      102.2±48.0     \<0.0001
  Diabetes, % (n)                                                              1.9 (1208)      7.1 (918)      11.2 (345)     \<0.0001   1.5 (417)       3.7 (292)      5.67 (188)     \<0.0001
  Treated diabetes, % (n)                                                      0.4 (255)       2.6 (333)      6.6 (202)      \<0.0001   0.8 (230)       2.0 (157)      3.7 (121)      \<0.0001
  Fasting blood glucose (mg/dL)                                                96.8±15.1       103.8±23.2     106.1±27.6     \<0.0001   90.9±13.8       97.0±17.7      99.4±20.3      \<0.0001
  Previous CV event, % (n)                                                     0.42 (265)      1.65 (212)     4.80 (148)     \<0.0001   0.46 (132)      1.36 (106)     2.14 (71)      \<0.0001
  Previous myocardial infarction, % (n)                                        0.13 (82)       0.87 (112)     2.92 (90)      \<0.0001   0.09 (26)       0.21 (16)      0.69 (23)      \<0.0001
  Previous stroke, % (n)                                                       0.29 (184)      0.81 (104)     2.01 (62)      \<0.0001   0.38 (109)      1.15 (90)      1.48 (49)      \<0.0001
  EKG changes, % (n)                                                           6.2 (3,843)     12.0 (1,515)   23.0 (681)     \<0.0001   4.7 (1,299)     9.8 (744)      17.4 (560)     \<0.0001
  Current smoker, % (n)                                                        35.4 (22,454)   25.0 (3,217)   15.5 (479)     \<0.0001   27.3 (7,822)    14.2 (1,109)   8,53 (283)     \<0.0001
  Physical activity, % (n)                                                     45.7 (28,982)   47.0 (6,055)   55.9 (1,725)   \<0.0001   40.6 (11,626)   46.7 (3,560)   49.2 (1,631)   \<0.0001
  High socioprofessional category, % (n)                                       42.4 (26,888)   48.6 (6,256)   58.0 (1,787)   \<0.0001   17.5 (5,008)    24.6 (1,916)   25.9 (857)     \<0.0001
  Total mortality, % (n)                                                       0.77 (489)      2.11 (272)     6.26 (193)     \<0.0001   0.34 (97)       1.21 (94)      3.44 (114)     \<0.0001

**Notes:** Comparisons between age groups were performed using ANOVA for quantitative variables and chi-square tests for dichotomous variables

≥102 cm in men and ≥88cm in women.

**Abbreviations:** ANOVA, analysis of variance; BMI, body mass index; CV, cardiovascular; DBP, diastolic blood pressure; EKG; electrocardiogram; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure; SEM, standard error of the mean.

###### 

All-cause mortality associated with obesity and related risk factors, according to age

                                             \<55 years                                                          55--65 years                                                        \>65 years
  ------------------------------------------ ------------------------------------------------------------------- ------------------------------------------------------------------- -------------------------------------------------------------------
  BMI (kg/m^2^)                              1.007 (0.985--1.030)                                                1.011 (0.983--1.040)                                                1.030 (0.998--1.062)
  WC (cm)                                    1.012 (1.004--1.020)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}     1.011 (1.000--1.021)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}     1.012 (1.001--1.023)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}
  BMI adjusted for WC (kg/m^2^)              0.943 (0.908--0.979)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}     0.960 (0.913--1.009)                                                1.007 (0.957--1.059)
  WC adjusted for BMI (cm)                   1.030 (1.016--1.043)[\*\*](#tfn6-vhrm-9-739){ref-type="table-fn"}   1.023 (1.005--1.042)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}     1.010 (0.993--1.028)
  Age (years)                                1.079 (1.066--1.092)[\*\*](#tfn6-vhrm-9-739){ref-type="table-fn"}   1.063 (1.023--1.104)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}     1.103 (1.074--1.133)[\*\*](#tfn6-vhrm-9-739){ref-type="table-fn"}
  Female sex                                 0.671 (0.518--0.870)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}     0.912 (0.664--1.252)                                                0.720 (0.521--0.995)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}
  Current smoker (yes/no)                    1.580 (1.204--2.072)[\*\*](#tfn6-vhrm-9-739){ref-type="table-fn"}   1.794 (1.577--2.042)[\*\*](#tfn6-vhrm-9-739){ref-type="table-fn"}   1.33 (1.138--1.555)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}
  Hypertension (yes/no)                      1.717 (1.442--2.042)[\*\*](#tfn6-vhrm-9-739){ref-type="table-fn"}   1.494 (1.196--1.865)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}     1.313 (1.012--1.705)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}
  Total cholesterol (mg/dL)                  0.999 (0.997--1.001)                                                1.000 (0.997--1.002)                                                0.997 (0.994--1.001)
  Triglycerides (mg/dL)                      1.000 (0.999--1.002)                                                0.999 (0.998--1.001)                                                1.001 (0.998--1.003)
  Diabetes (yes/no)                          1.397 (0.955--2.042)                                                1.654 (1.172--2.336)[\*](#tfn5-vhrm-9-739){ref-type="table-fn"}     1.038 (0.689--1.565)
  High socioprofessional category (yes/no)   0.576 (0.511--0.649)[\*\*](#tfn6-vhrm-9-739){ref-type="table-fn"}   0.874 (0.759--1.007)                                                1.049 (0.859--1.281)

**Notes:** Mortality was analyzed using multiple Cox regression models. Data are expressed as hazard ratios (95% confidence intervals). For nonbinary variables, the hazard ratio corresponds to the change in risk per unit (specified in parentheses) of the variable. The model included age, sex, diabetes, hypertension, total cholesterol and triglycerides, current smoking, socioprofessional category, physical activity, and family history of CV disease and diabetes.

*P*\<0.05

*P*\<0.0001.

**Abbreviations:** BMI, body mass index; WC, waist circumference.

[^1]: †Ulrich M Vischer passed away on March 19, 2012
